The U.S. Oncology business is preparing for the potential U.S. launch of an mRNA-based individualized neoantigen therapy for early-stage melanoma, developed through an alliance partnership. The Associate Director will lead commercial process strategy and integration for the Intismeran treatment journey, designing and continuously improving the operating model that supports therapy delivery across a complex treatment ecosystem. Reporting to the Director, Individualized Therapy Operations, this role serves as the commercial lead and primary commercial representative across operational teams and external partners. The role integrates workflows, governance, stakeholder activities, and supporting technologies across treatment sites, pathology laboratories, sequencing providers, manufacturing and logistics partners, distributors, alliance stakeholders, and internal teams. It identifies and removes operational barriers, enhances customer and treatment-site experiences, and supports treatment completion, operational excellence, and future scalability.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director